BORTEZOMIB TEVA 1 MG

Страна: Израиль

Язык: английский

Источник: Ministry of Health

Активный ингредиент:

BORTEZOMIB

Доступна с:

ABIC MARKETING LTD, ISRAEL

код АТС:

L01XX32

Фармацевтическая форма:

POWDER FOR SOLUTION FOR INJECTION

состав:

BORTEZOMIB 1 MG

Администрация маршрут:

I.V

Тип рецепта:

Required

Производитель:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

Терапевтические области:

BORTEZOMIB

Терапевтические показания :

Bortezomib Teva is indicated for the treatment of patients with multiple myeloma. Bortezomib Teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Bortezomib Teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation

Дата Авторизация:

2017-07-04